Literature DB >> 9366313

Simultaneous bilateral percutaneous nephrolithotomy.

J W Dushinski1, J E Lingeman.   

Abstract

PURPOSE: We evaluate the results of simultaneous bilateral percutaneous nephrolithotomy.
MATERIALS AND METHODS: The charts of 52 patients scheduled for simultaneous bilateral percutaneous nephrolithotomy at the Methodist Hospital of Indiana were retrospectively reviewed. The results of the 48 patients who underwent the procedure were tabulated and analyzed.
RESULTS: Mean operative time was 269 minutes and mean hospital stay was 5.6 days. Of the patients 45 were rendered stone-free (96.9% of 96 renal units) and 3 had insignificant debris (fragments less than 4 mm.) unilaterally. Complications were infrequent and included hydrothorax in 5 cases, ureteral obstruction by fragment migration in 2, hematuria causing clot retention in 2, blood transfusion in 2 and ureteral perforation with a guide wire in 1.
CONCLUSIONS: Simultaneous bilateral percutaneous nephrolithotomy is a well tolerated, safe, cost-effective and expeditious approach to patients with bilateral renal calculi requiring percutaneous nephrolithotomy.

Entities:  

Mesh:

Year:  1997        PMID: 9366313     DOI: 10.1016/s0022-5347(01)68154-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Simultaneous bilateral tubeless percutaneous nephrolithotomy of staghorn stones: a prospective randomized controlled study.

Authors:  Chung-Jing Wang; Chien-Hsing Chang; Shi-Wei Huang
Journal:  Urol Res       Date:  2010-12-16

2.  Clinical outcomes of the simultaneous bilateral percutaneous nephrolithotomy (PCNL) in patients with kidney stones: A prospective cohort study.

Authors:  Mohammad Reza Darabi; Salman Soltani; Alireza Akhavan Rezayat; Masoud Yousefi; Mehdi Kashefi; Mahmoud Tavakkoli; Shabnam Mohammadi
Journal:  Electron Physician       Date:  2018-02-25

Review 3.  Prone percutaneous nephrolithotomy: its advantages and our technique for puncture.

Authors:  Diego M Carrion; José Ramón Cansino; Luis M Quintana; Juan Gómez Rivas; Juan Antonio Mainez Rodriguez; José Ramón Pérez-Carral; Luis Martínez-Piñeiro
Journal:  Transl Androl Urol       Date:  2018-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.